Asymmetric synthesis and anti-HIV activity of L-carbocyclic 2′,3′-didehydro-2′,3′-dideoxyadenosine
- 1 July 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (13) , 1585-1588
- https://doi.org/10.1016/s0960-894x(98)00278-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitroBioorganic & Medicinal Chemistry Letters, 1997
- Anti-human immunodeficiency and anti-hepatitis B virus activities of β-l-2′,3′-dideoxy purine nucleosidesBioorganic & Medicinal Chemistry Letters, 1996
- Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virusAntimicrobial Agents and Chemotherapy, 1995
- Synthesis of carbocyclic nucleosidesTetrahedron, 1994
- Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication.Published by Elsevier ,1992
- Asymmetric synthesis of 1,3-dioxolane-pyrimidine nucleosides and their anti-HIV activity.Journal of Medicinal Chemistry, 1992
- Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytesAntimicrobial Agents and Chemotherapy, 1992
- Synthesis of chiral carbocyclic nucleosidesTetrahedron, 1992
- Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosidesJournal of Medicinal Chemistry, 1990
- Potent and selective activity of a new carbocyclic nucleoside analog (Carbovir: NSC 614846) against human immunodeficiency virus In vitroBiochemical and Biophysical Research Communications, 1988